Bacterial endotoxins trigger pyrogenic reactions that can progress from fever and chills to life-threatening septic shock, making endotoxin control fundamental to patient safety for any device or product contacting sterile body compartments. Endotoxin testing using quantitative kinetic chromogenic LAL methodology provides rapid, sensitive detection of bacterial endotoxins essential for ensuring that medical devices and pharmaceutical products won't trigger dangerous pyrogenic responses when contacting sterile body compartments or bloodstream. This validated assay following Ph. Eur., USP, and AAMI ST72 quantifies endotoxin levels from 0.005 to 50 EU/ml through kinetic measurement of chromogenic substrate cleavage, delivering results within hours compared to days required by rabbit pyrogen testing while providing superior sensitivity and objectivity. Injectable devices, implantables, and products contacting blood require endotoxin testing as fundamental release criteria, with regulatory specifications typically demanding endotoxin levels below 0.5 EU/ml for most applications and even lower limits for intrathecal devices or large-volume parenterals where endotoxin exposure creates life-threatening septic responses. The kinetic measurement approach continuously monitors reaction progression, enabling precise endotoxin quantification across wide concentration ranges while internal controls validate each test confirming reagent performance and absence of interference affecting result reliability. Medical device manufacturers rely on endotoxin testing throughout product lifecycle - validating cleaning processes remove endotoxin contamination, demonstrating that sterilization procedures don't generate endotoxin through bacterial cell lysis, and performing routine batch release testing ensuring consistent endotoxin control. For reusable medical devices, endotoxin testing validates cleaning and reprocessing protocols per AAMI ST72, demonstrating that reprocessing consistently reduces endotoxin to safe levels despite repeated contamination during clinical use.